These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2043774)

  • 1. Resolution of a linguistic dilemma.
    Janković GM
    Blood; 1991 Jun; 77(12):2793-4. PubMed ID: 2043774
    [No Abstract]   [Full Text] [Related]  

  • 2. CML with complex chromosome rearrangements and dysplastic megakaryocytes.
    Xu Z; McGowan-Jordan J
    Blood; 2016 Jul; 128(4):604. PubMed ID: 28092904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML)].
    Kitamura T; Watanabe-Okochi N; Inoue D; Togami K; Uchida T; Kagiyama Y; Kawabata K; Chiba S; Harada Y; Harada H; Kitaura J; Nakahara F
    Rinsho Ketsueki; 2012 Aug; 53(8):734-9. PubMed ID: 22975812
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
    Thiele J; Titius BR; Kopsidis C; Fischer R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 7. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
    Advani AS
    Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
    Onozawa M; Fukuhara T; Takahata M; Yamamoto Y; Miyake T; Maekawa I
    Ann Hematol; 2003 Sep; 82(9):593-5. PubMed ID: 12898186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
    Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
    Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy.
    Goldberg SL; Madan RA; Rowley SD; Pecora AL; Hsu JW; Tantravahi R
    Blood; 2003 Jan; 101(2):781. PubMed ID: 12509385
    [No Abstract]   [Full Text] [Related]  

  • 11. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
    Nakase K; Kita K; Kyo T; Katayama N
    Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
    Marisavljević D; Rolović Z; Mitrović D
    Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on CFU-Mix in 54 cases of leukemia and myelodysplastic syndrome].
    Chen Y; Wang BM; Li CY
    Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):35-8, 62-3. PubMed ID: 2737036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell origin of human myeloid blood cell neoplasms.
    Fialkow PJ
    Verh Dtsch Ges Pathol; 1990; 74():43-7. PubMed ID: 1708632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelomonocytic leukemia with overlap dysplastic/proliferative presentation.
    Gologan R; Stoia R; Radulescu I; Georgescu D; Ostroveanu D
    Leuk Res; 2007 Jun; 31(6):878-9. PubMed ID: 16956659
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on CFU-mix of 47 patients with leukemia and myelodysplastic syndrome.
    Chen Y; Wang BM; Li CY; Yu DJ
    Chin Med J (Engl); 1989 Jun; 102(6):425-30. PubMed ID: 2512062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome abnormalities in hematopoietic malignancies.
    Kamada N
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1332-8. PubMed ID: 3073610
    [No Abstract]   [Full Text] [Related]  

  • 19. G-CSF for chromosome analysis of myeloid leukemias and MDS.
    Tsuchiya H; Higuchi S; Asou N; Yamaguchi K; Matsuda I; Yokoyama Y; Murakami T; Kaneko Y
    Cancer Genet Cytogenet; 1990 Jul; 47(2):277-9. PubMed ID: 1694102
    [No Abstract]   [Full Text] [Related]  

  • 20. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.